cambridge's bluebird bio licenses delivery tech to novartis, gsk..
.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
suven life sciences' pashamylaram facility successfully completes usfda inspection